Clinical Trial: Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Randomized, Double Blind, Placebo Controlled, Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes

Brief Summary: To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes.

Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.

Current Primary Outcome: Corneal-conjunctival staining [ Time Frame: 4 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Kissei Pharmaceutical Co., Ltd.

Dates:
Date Received: July 22, 2008
Date Started:
Date Completion:
Last Updated: March 16, 2009
Last Verified: March 2009